Big pharma was hit by its refusal to make antiretroviral drugs available cheaply for HIV/AIDS sufferers in developing countries.

• 大药厂由于拒绝以便宜的价格为发展中国家的HIV/AIDS受害者提供抗逆转录病毒的药物而名誉扫地。